πŸ‡ΊπŸ‡Έ FDA
Patent

US 10639308

sGC stimulators

granted A61KA61K31/506A61K31/517

Quick answer

US patent 10639308 (sGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/519, A61K31/5377